Abbott Intrinsic Value
Abbott intrinsic value. Abbott (ABBOTINDIA) median intrinsic value is ₹10761.90 from 10 valuation models (range ₹5072–₹26240), vs current price ₹25360.00 — -57.6% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ABBOTINDIA share price.
ABBOTINDIA Valuation Methods Summary — DCF, Graham Number & P/E
Abbott intrinsic value across 10 models vs current price ₹25360.00 — upside/downside and value range per method. Compare with ABBOTINDIA stock valuation models to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹16715.60 | ₹13372.48 - ₹20058.72 | -34.1% | EPS: ₹759.80, Sector P/E: 22x |
| Book Value Method | asset | ₹5072.00 | ₹4564.80 - ₹5579.20 | -80.0% | Book Value/Share: ₹2273.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹7608.00 | ₹6847.20 - ₹8368.80 | -70.0% | Revenue/Share: ₹3473.81, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹10761.90 | ₹9685.71 - ₹11838.09 | -57.6% | EBITDA: ₹2260.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹10144.00 | ₹8115.20 - ₹12172.80 | -60.0% | CF Growth: 8.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹8628.20 | ₹7765.38 - ₹9491.02 | -66.0% | EPS Growth: 14.2%, Fair P/E: 11.4x |
| Growth Adjusted P/E | growth | ₹11813.09 | ₹10631.78 - ₹12994.40 | -53.4% | Revenue Growth: 7.3%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹12680.00 | ₹11412.00 - ₹13948.00 | -50.0% | ROE: 33.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹7608.00 | ₹6847.20 - ₹8368.80 | -70.0% | EPS: ₹759.80, BVPS: ₹2273.33 |
| Dividend Yield Method | dividend | ₹26240.00 | ₹23616.00 - ₹28864.00 | +3.5% | DPS: ₹656.00, Target Yield: 2.5% |
ABBOTINDIA Intrinsic Value vs Market Price — All Valuation Models
Abbott fair value range ₹5072–₹26240 vs current market price ₹25360.00 across 10 valuation models. Read ABBOTINDIA dividend growth for the complete payout history and dividend yield track record.
ABBOTINDIA Intrinsic Value Analysis — Undervalued or Overvalued?
Abbott median intrinsic value ₹10761.90, current price ₹25360.00 — Trading Above Calculated Value by 57.6%, margin of safety -100.0%.
What is the intrinsic value of ABBOTINDIA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Abbott (ABBOTINDIA) is ₹10761.90 (median value). With the current market price of ₹25360.00, this represents a -57.6% variance from our estimated fair value.
The valuation range spans from ₹5072.00 to ₹26240.00, indicating ₹5072.00 - ₹26240.00.
Is ABBOTINDIA undervalued or overvalued?
Based on our multi-method analysis, Abbott (ABBOTINDIA) appears to be trading above calculated value by approximately 57.6%.
ABBOTINDIA Financial Health — Key Ratios vs Industry Benchmarks
Abbott financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 33.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.12x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ABBOTINDIA Cash Flow Quality — Operating & Free Cash Flow
Abbott operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1,319 Cr | ₹1,134 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,012 Cr | ₹1,012 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,213 Cr | ₹1,005 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹893 Cr | ₹819 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹948 Cr | ₹750 Cr | Positive Free Cash Flow | 8/10 |